Advanced BioDesign
Ismail CEYLAN serves as the Président and CEO of Advanced Biodesign since August 2010, where the company has pioneered a novel therapeutic strategy targeting cancer by inhibiting the intracellular detoxification mechanisms utilized by cancerous cells to evade apoptosis. Prior to this role, Ismail CEYLAN was the Technical Director and Research Engineer at Covalab from 2000 to 2010, contributing to innovations in the field.
This person is not in any teams
Advanced BioDesign
Advanced BioDesign, as an immunotechnology specialist, provides a tailored and high value solution to their research. This new company keeps his main research activity in Oncology, Infectious Diseases and in Neuroscience Fields. One of its major strengths is to follow its customers during the development of their own kits, from the feasibility tothe technology transfer.